|

SHR2554; SHR-A2102 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Locally Advanced or Metastatic Non-small Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Other1 trial

Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.